Intensity of Past Smoking Linked to COVID-19 Severity

Intensity of Past Smoking Linked to COVID-19 Severity

15 Feb, 2021

Cumulative exposure to cigarette smoke was associated with more severe outcomes among individuals testing positive for COVID-19, including higher risks of hospitalization and death, researchers found.

Compared with never smokers, those with smoking histories of more than 30 pack-years had 2.25 higher odds of hospitalization due to COVID-19 (95% CI 1.76-2.88), after adjustment for age, race, and sex, reported Katherine Lowe, MSc, of Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, and colleagues in a JAMA Internal Medicine research letter.

Mortality risk was also substantially higher in heavy smokers (OR 1.89 95% CI 1.29-2.76) after those adjustments. But when further adjusted for comorbidities and use of certain medications, the association with mortality diminished into nonsignificance.

Additionally, odds ratios were intermediate for smokers with less cumulative exposure, pointing to a dose-response relationship.

Previous smoking appeared to be the key risk factor, as odds ratios for severe outcomes were similar for current smokers and those who had quit, Lowe and colleagues said.

The CDC currently lists smokers as one of the groups at high risk for severe COVID-19; yet research on the role of smoking in COVID-19 outcomes has been "limited and contradictory," Lowe's group wrote, with no studies having assessed cumulative smoking exposure in pack-years.

The group drew on data from the COVID-19 Registry for roughly 7,000 patients in Ohio and Florida, of whom about 6,000 had never smoked. Adults testing positive for COVID-19 from March 8 to August 25 and had full smoking information available were included.

Smokers with more than 30 pack-years were older (mean age 71 vs 49 for never smokers) and significantly more likely to be white (72% vs 56%, respectively) and have obesity (37% vs 27%). Heavy smokers were also significantly more likely to have comorbidities, including 86% with hypertension versus 37% of never smokers.

Limitations to the study include use of data exclusively from tertiary care medical centers, which limits its generalizability to the population at large. They also noted former smokers might have been recorded as never smokers, and pack-years potentially underestimated.

Image retrieved from Unsplash. 

Reference: https://www.medpagetoday.com/infectiousdisease/covid19/90871


stay updated

READ ALSO

03 June, 2026

KRATOS Energy Drink — Τέσσερα Αμερικανικά Functional Ποτά Κάνουν Την Εμφάνισή Τους στην Αθήνα

Read more

28 May, 2026

The $300 billion functional beverage market is restructuring. Sugar taxes, clean-label demand, and a generational consumer shift are redistributing market share. Tobacco International Inc. is positioning KRATOS as its vehicle to capitalize on the opportunity.

Read more

15 May, 2026

An in-depth look at KRATOS®, a global lifestyle brand redefining the intersection of energy and modern oral nicotine. Engineered for high-performance individuals, KRATOS® delivers zero-sugar functional beverages and premium nicotine pouches designed for precision, focus, and forward momentum.

Read more

You must verify that you are over the age of 21 to enter this site.

We use cookies to improve your experience on our site. By continuing to browse it, you agree to our use of cookies. Learn more.